D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$497M |
| 2 |
Bank of America
BAC
|
+$342M |
| 3 |
Costco
COST
|
+$332M |
| 4 |
Procter & Gamble
PG
|
+$332M |
| 5 |
Meta Platforms (Facebook)
META
|
+$305M |
Top Sells
| 1 |
Marathon Petroleum
MPC
|
+$504M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$387M |
| 3 |
Pfizer
PFE
|
+$366M |
| 4 |
Advanced Micro Devices
AMD
|
+$331M |
| 5 |
Walmart
WMT
|
+$320M |
Sector Composition
| 1 | Technology | 17.19% |
| 2 | Financials | 14.3% |
| 3 | Healthcare | 10.79% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Lattice Semiconductor
LSCC
$8.82B
| $467K | ﹤0.01% |
9,626
+445
| +5% | +$21.6K |
|
2902
Compañía de Cervecerías Unidas
CCU
$2.21B
| $466K | ﹤0.01% |
36,927
-23,870
| -39% | -$301K |
|
|
PMT
2903
PennyMac Mortgage Investment
PMT
$1.07B
| $466K | ﹤0.01% |
33,682
+18,222
| +118% | +$252K |
|
2904
Supernus Pharmaceuticals
SUPN
$2.55B
| $466K | ﹤0.01% |
16,100
+8,360
| +108% | +$242K |
|
2905
Elbit Systems
ESLT
$23.6B
| $465K | ﹤0.01% |
2,026
-4,797
| -70% | -$1.1M |
|
2906
NovoCure
NVCR
$1.36B
| $460K | ﹤0.01% |
+6,614
| New | +$460K |
|
2907
LG Display
LPL
$4.46B
| $459K | ﹤0.01% |
82,285
-223,098
| -73% | -$1.24M |
|
2908
Devon Energy
DVN
$22.1B
| $458K | ﹤0.01% |
+8,315
| New | +$458K |
|
2909
Columbus McKinnon
CMCO
$415M
| $457K | ﹤0.01% |
+16,096
| New | +$457K |
|
2910
VTEX
VTEX
$742M
| $457K | ﹤0.01% |
148,329
-47,044
| -24% | -$145K |
|
2911
Globalstar
GSAT
$3.79B
| $455K | ﹤0.01% |
24,644
-3,083
| -11% | -$56.9K |
|
2912
1stdibs.com
DIBS
$101M
| $454K | ﹤0.01% |
79,812
+43,355
| +119% | +$247K |
|
|
SGFY
2913
DELISTED
Signify Health, Inc.
SGFY
| $454K | ﹤0.01% |
32,907
-127,688
| -80% | -$1.76M |
|
2914
CytomX Therapeutics
CTMX
$330M
| $453K | ﹤0.01% |
247,477
+77,526
| +46% | +$142K |
|
2915
Goodyear
GT
$2.43B
| $453K | ﹤0.01% |
+42,305
| New | +$453K |
|
2916
BlackRock Corporate High Yield Fund
HYT
$1.54B
| $453K | ﹤0.01% |
47,500
| – | – |
|
|
MLGO
2917
MicroAlgo
MLGO
$97.2M
| $452K | ﹤0.01% |
7
| – | – |
|
2918
AngioDynamics
ANGO
$433M
| $451K | ﹤0.01% |
23,327
-1,123
| -5% | -$21.7K |
|
|
AMTI
2919
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $451K | ﹤0.01% |
154,967
-74,673
| -33% | -$217K |
|
|
MBSC
2920
DELISTED
M3-Brigade Acquisition III Corp.
MBSC
| $451K | ﹤0.01% |
45,200
| – | – |
|
|
HSKA
2921
DELISTED
Heska Corp
HSKA
| $451K | ﹤0.01% |
4,775
-1,260
| -21% | -$119K |
|
2922
Playboy, Inc. Common Stock
PLBY
$173M
| $450K | ﹤0.01% |
70,284
+25,773
| +58% | +$165K |
|
2923
Farmers National Banc Corp
FMNB
$554M
| $448K | ﹤0.01% |
29,846
-22,104
| -43% | -$332K |
|
|
BNFT
2924
DELISTED
Benefitfocus, Inc.
BNFT
| $448K | ﹤0.01% |
57,585
-20,239
| -26% | -$157K |
|
2925
MakeMyTrip
MMYT
$9.31B
| $447K | ﹤0.01% |
17,404
+8,993
| +107% | +$231K |
|